The EML4-ALK fusion occurs due to a chromosomal rearrangement where parts of chromosome 2 are broken and rejoined incorrectly. This rearrangement leads to the fusion of the EML4 and ALK genes, resulting in the creation of a chimeric protein with oncogenic properties.
